Splenic Irradiation and Late Volume Changes Following Stereotactic Ablative Radiotherapy (SABR) for Adrenal Tumors

被引：0
|
作者：
Giraud, N. [1 ]
Schneiders, F. L. [1 ]
de Koste, J. R. van Sornsen [1 ]
Palacios, M. A. [1 ]
Senan, S. [1 ]
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2844
引用
收藏
页码：E385 / E386
页数：2
相关论文
共 50 条
  • [21] Imaging follow-up after stereotactic ablative radiotherapy (SABR) for lung tumors
    Lo, Simon S.
    Teh, Bin S.
    Mayr, Nina A.
    Chiang, Stephen B.
    Huang, Zhibin
    Yao, Min
    Machtay, Mitchell
    JOURNAL OF RADIATION ONCOLOGY, 2012, 1 (01) : 11 - 16
  • [22] Stereotactic Ablative Radiotherapy (SABR) for Pulmonary Oligometastases and Oligoprogression
    Helou, Joelle
    Thibault, Isabelle
    Yeung, Latifa L.
    Poon, Ian
    Tjong, Michael
    Chiang, Andrew
    Jain, Suneil
    Soliman, Hany
    Cheung, Patrick
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S636 - S636
  • [23] Time Course and Predictive Factors for Lung Volume Reduction Following Stereotactic Ablative Radiation Therapy (SABR) of Lung Tumors
    Binkley, M. S.
    Shrager, J. B.
    Chaudhuri, A.
    Popat, R.
    Maxim, P. G.
    Shultz, D. B.
    Diehn, M.
    Loo, B. W., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E424 - E424
  • [24] Identifying dosimetric predictors of toxicity in multiple lung tumors treated with stereotactic ablative radiotherapy (SABR)
    Tekatli, H.
    Tetar, S.
    Warner, A.
    Palma, D.
    Verbakel, W.
    Nguyen, T.
    Spoelstra, F.
    Gaede, S.
    Slotman, B.
    Senan, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S143 - S143
  • [25] Tumor volume changes during stereotactic ablative radiotherapy for adrenal gland metastases under MRI guidance
    Giraud, Nicolas
    Schneiders, Famke L.
    de Koste, John R. van Sornsen
    Palacios, Miguel A.
    Senan, Suresh
    RADIOTHERAPY AND ONCOLOGY, 2023, 186
  • [26] LATE OUTCOMES OF STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR CENTRALLY LOCATED STAGE I LUNG CANCER
    Haasbeek, Cornelis J.
    Lagerwaard, Frank J.
    Slotman, Ben
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S542 - S543
  • [27] Does Histological Subtype Affect Outcomes in Stereotactic Ablative Body Radiotherapy (SABR) for Lung Tumors?
    Allos, B.
    Mascall, S.
    Vreugdenhil, M.
    Watkins, S.
    Stevenson, R.
    Ghafoor, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2179 - S2180
  • [28] Clinical implementation of stereotactic ablative radiotherapy (SABR) for NSCLC in the UK
    Baker, A.
    Clark, C.
    Ciurlionis, L.
    Distefano, G.
    Hatton, M.
    Jain, P.
    Lilley, J.
    Mayles, H.
    Miles, E.
    Scott, A.
    Webster, G.
    LUNG CANCER, 2013, 79 : S61 - S61
  • [29] Radiobiology of stereotactic ablative radiotherapy (SABR): perspectives of clinical oncologists
    Li, Shan
    Shen, Liangfang
    JOURNAL OF CANCER, 2020, 11 (17): : 5056 - 5068
  • [30] Technical know-how in stereotactic ablative radiotherapy (SABR)
    Lo, Simon S.
    Foote, Matthew
    Siva, Shankar
    Slotman, Ben J.
    Teh, Bin S.
    Guckenberger, Matthias
    Tan, Daniel
    Mayr, Nina A.
    Sahgal, Arjun
    JOURNAL OF MEDICAL RADIATION SCIENCES, 2016, 63 (01): : 5 - 8
12345